Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
Clinical trial NCT06784791 · RECRUITING
Trial details
- NCT number
- NCT06784791
- Sponsor
- University Hospital, Essen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2027-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.